Cell-specific and endothelium-dependent regulations of matrix metalloproteinase-2 in rat aorta

Basic Research in Cardiology

Volumn 109, Issue 4, 2014, Pages

  Kopaliani, Irakli ^a   Martin, Melanie ^a   Zatschler, Birgit ^a   Bortlik, Katrin ^a   Müller, Bianca ^a   Deussen, Andreas ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Angiotensin II; Matrix metalloproteinase; Vascular remodelling

Indexed keywords

ANGIOTENSIN II; GELATINASE A; JANUS KINASE 2; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; EGFR PROTEIN, RAT; ENZYME PRECURSOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE; JAK2 PROTEIN, RAT; MMP2 PROTEIN, RAT; PROGELATINASE; PROTEIN C JUN; STAT3 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; AORTA; ARTICLE; CELL ACTIVITY; CELL FUNCTION; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; TIME; UPREGULATION; VASCULAR SMOOTH MUSCLE; WISTAR KYOTO RAT;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; AORTA; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENZYME ACTIVATION; ENZYME PRECURSORS; GELATINASES; JANUS KINASE 2; MALE; MATRIX METALLOPROTEINASE 2; MITOGEN-ACTIVATED PROTEIN KINASE 8; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTO-ONCOGENE PROTEINS C-JUN; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS; UP-REGULATION;

EID: 84901868780     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-014-0419-8     Document Type: Article

References (40)

1. Albaladejo P, Bouaziz H, Duriez M, Gohlke P, Levy BI, Safar ME, Benetos A (1994) Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats. Hypertension 23:74-82. doi:10.1161/01.HYP.23.1.74 (Pubitemid 24022047)
2. Arenas I, Xu Y, Lopez-Jaramillo P, Davidge ST (2003) Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha. Am J Physiol Cell Physiol 286:779-784. doi:10.1152/ajpcell.00398.2003
3. Basalyga DM, Simionescu DT, Xiong W, Baxter BT, Starcher BC, Vyavahare NR (2004) Elastin degradation and calcification in an abdominal aorta injury model. Circulation 110:3480-3487. doi:10.1161/01.CIR.0000148367.08413.E9 (Pubitemid 39602227)
4. Berk BC, Corson MA (1997) Angiotensin II signal transduction in vascular smooth muscle, role of tyrosine kinases. Circ Res 80:607-616. doi:10.1161/01.RES.80.5.607 (Pubitemid 27181343)
5. Boutouyrie P, Bussy C, Hayoz D, Hengstler J, Dartois N, Laloux B, Brunner H, Laurent S (2000) Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment. Circulation 101:2601-2606. doi:10.1161/01.CIR.101.22.2601 (Pubitemid 30350638)
6. Browatzki M, Larsen D, Pfeiffer C, Gehrke SG, Schmidt J, Kranzhofer A, Katus H (2008) Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redoxsensitive manner. J Vasc Res 42:415-423. doi:10.1016/j.regpep. 2007.12.005
7. Bunkenburg B, van Amelsvoort T, Rogg H, Wood JM (1992) Receptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension 20:746-754. doi:10.1161/01.HYP.20. 6.746
8. Chen LC, Noelken ME, Nagase H (1993) Disruption of the cysteine-75 and zinc ion coordination is not sufficient to activate the precursor of human matrix metalloproteinase 3 (stromelysin 1). Biochemistry 32:10289-10295 (Pubitemid 23320151)
9. Cho A, Graves J, Reidy MA (2000) Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20:2527-2532. doi:10.1161/01.ATV.20.12.2527
10. Desk R, Williams L, Health K (2011) Matrix metalloproteinases in vascular remodelling and atherogenesis. Circ Res 90:251-262. doi:10.1161/hh0302.105345
11. Dzau VJ (1984) Vascular renin-angiotensin: a possible autocrine or paracrine system in control. J Cardiovasc Pharmacol 6:377-382
12. Frohlich ED, Sasaki O (1990) Dissociation of changes in cardiovascular mass and performance with angiotensin-converting enzyme inhibitors in Wistar-Kyoto and spontaneously hypertensive rats. J Am Coll Cardiol 16:1492-1499. doi:10.1016/0735- 1097(90)90397-8
13. Gum R, Wang H, Lengyel E, Juarez J, Boyd D (1997) Regulation of 92 kDa type IV collagenase expression by the jun amino terminal kinase- and the extracellular signal-regulated kinasedependent signalling cascades. Oncogene 14:1481-1493 (Pubitemid 27182438)
14. Hanemaaijer R, Koolwijk P, Wil JA, Hinsbergh V (1993) Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Biochem J 809:803-809
15. Ishi T, Asuwa N (2000) Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in aortic dissection. Hum Pathol 31:640-646. doi:10.1053/hupa.2000.7642
16. Ishiguro K, Hayashi K, Sasamura H, Sakamaki Y, Itoh H (2009) "Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension. Hypertension 53:83-89. doi:10.1161/HYPERTENSIONAHA.108.122721
17. Jiménes E, Pérez de la Blanca E, Urso L, González I, Salas J, Montiel M (2009) Angiotensin II induces MMP-2 activity via FAK/JNK pathway in human endothelial cells. BBRC 380:769-774. doi:10.1016/j.bbrc.2009. 01.142
18. Lee Jin-Hee, Johnson Peter RA, Roth Michael, Hunt Nicholas H, Black Judith L (2001) ERK activation and mitogenesis in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 280:1019-1029
19. Keshet Y, Seger R (2010) The MAP kinase signalling cascades: a system of hundreds of components regulates a diverse array of physiological functions. Methods Mol Biol 661:3-38. doi:10.1007/978-1-60761-795-2-1
20. Knox JB, Sukhova GK, Whittemore AD, Libby P (1997) Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 95:205-212. doi:10.1161/01.CIR.95.1.205 (Pubitemid 27029964)
21. Kroll K, Kelm MK, Burrig KF, Schrader J (1989) Transendothelial transport and metabolism of adenosine and inosine in the intact rat aorta. Circ Res 64:1147-1157. doi:10.1161/01.RES.64.6.1147
22. Lee YJ, Lee EB, Kwon YE, Lee JJ, Cho WS, Kim H, Song YW (2003) Effect of estrogen on the expression of matrix metalloproteinase (MMP)-1, MMP-3, and MMP-13 and tissue inhibitor of metalloproternase-1 in osteoarthritis chondrocytes. Rheumatol Int 23:282-288. doi:10.1007/s00296-003-0312-5 (Pubitemid 37518611)
23. Liacini A, Sylvester J, Li WQ, Huang W, Dehnade F, Ahmad M, Zafarullaha M (2003) Induction of matrix metalloproteinase- 13 gene expression by TNF-α is mediated by MAP kinases, AP-1, and NF-κB transcription factors in articular chondrocytes. Exp Cell Res 288:208-217. doi:10.1016/S0014-4827(03) 00180-0 (Pubitemid 36871010)
24. Makowski GS, Ramsby ML (2005) Autoactivation profiles of calcium-dependent matrix metalloproteinase-2 and -9 in inflammatory synovial fluid: effect of pyrophosphate and bisphosphonates. Clin Chem Acta 358:182-191. doi:10.1016/j.cccn.2005.03.012 (Pubitemid 40966647)
25. Jamil Mayet, Stanton AV, Sinclair A-M, MacKay J, Shahi M, Foale RA, Nicolaides A, Poulter NR, Sever PS, McG. Thom SA, Hughes AD (1995) The effects of antihypertensive therapy on carotid vascular structure in man. Cardiovasc Res 30:147-152. doi:10.1016/S0008-6363(95)00026-7
26. Nagase H (1997) Activation mechanisms of matrix metalloproteinases. Biol Chem 387:151-160
27. Nagase H, Woessner JF (1999) Matrix metalloproteinases. J Biol Chem 274:21491-21494. doi:10.1074/jbc.274.31.21491 (Pubitemid 129519680)
28. Naftilan AJ, Pratt RE, Dzau VJ (1989) Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 83:1419-1424 (Pubitemid 19113061)
29. Naito T, Masaki T, Nikolic-Paterson DJ, Tanji C, Yorioka N, Kohno N (2004) Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1. Am J Physiol Renal Physiol 286:278-287. doi:10.1152/ajprenal.00139.2003
30. Fabunmi Rosalind P, Baker Andrew H, Murray Edward J, Booth Robert FG, Newby Andrew C (1996) Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors of metalloproteinases-1, -2 and -3 in rabbit aortic smooth muscle cells. Biochem J 315:335-342
31. Safar ME, Girerd X, Laurent S (1996) Structural changes of large conduit arteries in hypertension. J Hypertens 14:545-555 (Pubitemid 26161108)
32. Safar ME, Levy BI, Struijker-Boudier H (2003) Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 107:2864-2869. doi:10.1161/01.CIR.0000069826.36125.B4 (Pubitemid 36705999)
33. Stetler-Stevenson WG (1994) Progelatinase A activation during tumor cell invasion. Invas Metastas 14:259-268
34. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase: isolation of the activated form of the membrane metalloprotease. J Biol Chem 270:5331-5338. doi:10.1074/jbc.270.10.5331
35. Toth M, Fridman R (2001) Assessment of gelatinases (MMP-2 and MMP-9) by gelatine zymography. In: Brooks SA, Schumacher U (eds) Metastasis Research Protocols, vol 1, 1st edn. Springer, Totowa, pp 163-173
36. Tyagi SC, Matsubara L, Weber KT (1993) Direct extraction and estimation of collagenase(s) activity by zymography in microquantities of rat myocardium and uterus. Clin Biochem 26:191-198. doi:10.1016/0009-9120(93)90025-2 (Pubitemid 23164945)
37. Van Wart HE, Birkedal-Hansen H (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 87:5578-5582. doi:10.1073/pnas.87.14.5578
38. Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827-839. doi:10.1161/01.RES.0000070112.80711.3D (Pubitemid 36542523)
39. Yang X, Zhu MJ, Sreejayan N, Ren J, Du M (2005) Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway. Mol Cell 20:263-270
40. Zatschler B, Dieterich P, Müller B, Kasper M, Rauen U, Deussen A (2009) Improved vessel preservation after 4 days of cold storage: experimental study in rat arteries. J Vasc Surg 50:397-406. doi:10.1016/j.jvs.2009.04.064